X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-27 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale | $2.05 | -9,834 | 41,629 | -19% | -$20,190 | |||||
2021-03-02 | SILK | Silk Road Medical Inc | Rogers Erica J. | Pres, CEO | S - Sale | $56.62 | -1,651 | 267,988 | -1% | -$93,478 | ||||||
| M | 2023-09-27 | TTOO | T2 Biosystems, Inc. | Cr Group L.P. | 10% | S - Sale | $0.17 | -13,130,147 | 0 | -100% | -$2,271,957 | |||||
2023-09-26 | NXGL | Nexgel, Inc. | Stein John Nachum | Dir | P - Purchase | $1.96 | +2,500 | 500,019 | +1% | +$4,900 | ||||||
2023-09-26 | TTOO | T2 Biosystems, Inc. | Cr Group L.P. | 10% | S - Sale | $0.20 | -5,392,920 | 13,130,147 | -29% | -$1,082,359 | ||||||
| M | 2023-09-26 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $43.29 | -10,000 | 5,017,950 | 0% | -$432,935 | |||||
| M | 2023-09-25 | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | S - Sale | $1.45 | -29,947 | 101,592 | -23% | -$43,459 | |||||
| AM | 2023-09-20 | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | S - Sale | $1.45 | -3,917 | 131,539 | -3% | -$5,675 | |||||
2023-09-26 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Pres, CCO | S - Sale | $192.12 | -4,000 | 47,905 | -8% | -$768,480 | ||||||
| M | 2023-09-25 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $12.66 | -179,375 | 5,713,636 | -3% | -$2,270,075 | |||||
2023-09-25 | TTOO | T2 Biosystems, Inc. | Cr Group L.P. | 10% | S - Sale | $0.25 | -250,000 | 18,523,067 | -1% | -$62,500 | ||||||
| M | 2023-09-22 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale | $2.13 | -7,393 | 51,463 | -13% | -$15,739 | |||||
2023-09-22 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $10.51 | -1,184 | 251,837 | 0% | -$12,444 | ||||||
2023-09-22 | TTOO | T2 Biosystems, Inc. | Cr Group L.P. | 10% | S - Sale | $0.26 | -5,079,344 | 18,773,067 | -21% | -$1,314,534 | ||||||
2023-09-21 | TTOO | T2 Biosystems, Inc. | Cr Group L.P. | 10% | S - Sale | $0.30 | -6,338,211 | 23,852,411 | -21% | -$1,904,632 | ||||||
| M | 2023-09-20 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale | $2.45 | -983 | 58,856 | -2% | -$2,413 | |||||
| M | 2023-09-20 | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | S - Sale | $1.45 | -3,917 | 131,539 | -3% | -$5,675 | |||||
2023-09-22 | DXCM | Dexcom Inc | Pacelli Steven Robert | EVP MD Dexcom V | S - Sale | $88.40 | -411 | 125,597 | 0% | -$36,332 | ||||||
2023-09-20 | TTOO | T2 Biosystems, Inc. | Cr Group L.P. | 10% | S - Sale | $0.31 | -7,753,710 | 30,190,622 | -20% | -$2,408,302 | ||||||
| D | 2023-09-20 | SWAV | Shockwave Medical, Inc. | Watkins Frank T | Dir | S - Sale+OE | $209.23 | -3,000 | 1,532 | -66% | -$627,690 | |||||
2023-09-19 | PODD | Insulet Corp | Singh Prem | SVP, Global Operations | P - Purchase | $168.92 | +1 | 4,032 | 0% | +$169 | ||||||
2023-09-19 | TTOO | T2 Biosystems, Inc. | Cr Group L.P. | 10% | S - Sale | $0.37 | -10,401,466 | 37,944,332 | -22% | -$3,806,937 | ||||||
2023-09-20 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale | $55.00 | -15,867 | 270,356 | -6% | -$872,685 | ||||||
| A | 2023-08-10 | STIM | Neuronetics, Inc. | Cascella Robert | Dir | P - Purchase | $1.81 | +28,500 | 162,848 | +21% | +$51,671 | |||||
| M | 2023-09-18 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $13.42 | -180,000 | 5,893,011 | -3% | -$2,415,000 | |||||
| M | 2023-09-18 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $45.90 | -10,000 | 5,027,950 | 0% | -$459,006 | |||||
| D | 2023-09-15 | SWAV | Shockwave Medical, Inc. | Godshall Douglas Evan | Pres, CEO | S - Sale+OE | $212.86 | -10,000 | 141,649 | -7% | -$2,128,615 | |||||
| M | 2023-09-15 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale | $2.45 | -9,269 | 59,839 | -13% | -$22,674 | |||||
2023-09-15 | DXCM | Dexcom Inc | Altman Steven R | Dir | S - Sale | $101.50 | -1,000 | 64,585 | -2% | -$101,495 | ||||||
2023-09-15 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $66.74 | -25,000 | 1,023,055 | -2% | -$1,668,503 | ||||||
2023-09-15 | TNDM | Tandem Diabetes Care Inc | McGroddy-Goetz Kathleen | Dir | P - Purchase | $21.45 | +1,000 | 9,032 | +12% | +$21,450 | ||||||
| D | 2023-09-15 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $146.35 | -5,675 | 453,450 | -1% | -$830,514 | |||||
2023-09-14 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | CEO | P - Purchase | $2.88 | +10,000 | 1,175,293 | +1% | +$28,773 | ||||||
2023-09-11 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $5.43 | +1,500 | 247,900 | +1% | +$8,145 | ||||||
| D | 2023-09-15 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $53.95 | -11,671 | 57,058 | -17% | -$629,694 | |||||
| M | 2023-09-13 | BEAT | Heartbeam, Inc. | De Urioste George | Dir | S - Sale | $2.05 | -10,000 | 69,108 | -13% | -$20,506 | |||||
2023-09-13 | PSTV | Plus Therapeutics, Inc. | Clowes Howard | Dir | P - Purchase | $1.43 | +6,993 | 11,693 | +149% | +$10,022 | ||||||
| M | 2023-09-12 | NXGL | Nexgel, Inc. | Henry Scott Robert | Dir | P - Purchase | $2.26 | +10,500 | 112,038 | +10% | +$23,750 | |||||
2023-09-14 | OFIX | Orthofix Medical Inc. | Hinrichs James F. | Dir | P - Purchase | $13.47 | +7,500 | 86,153 | +10% | +$101,025 | ||||||
| D | 2023-09-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $67.85 | -6,500 | 173,402 | -4% | -$441,040 | |||||
2023-09-12 | MODD | Modular Medical, Inc. | Sheibley Philip Brent | Dir | P - Purchase | $1.15 | +10,000 | 33,639 | +42% | +$11,500 | ||||||
2023-09-13 | NMTC | Neuroone Medical Technologies Corp | McClurg Ronald W. | CFO | P - Purchase | $0.98 | +50,900 | 130,400 | +64% | +$50,025 | ||||||
2023-09-11 | AKLI | Akili, Inc. | Studer Jacqueline | GC | S - Sale | $1.05 | -1,130 | 348,292 | 0% | -$1,187 | ||||||
2023-09-11 | AKLI | Akili, Inc. | Martucci Walter Edward II | CEO | S - Sale | $1.05 | -2,353 | 3,150,180 | 0% | -$2,471 | ||||||
2023-09-11 | AKLI | Akili, Inc. | Franklin Matthew | Pres, COO | S - Sale | $1.05 | -1,728 | 753,898 | 0% | -$1,814 | ||||||
2023-09-11 | AKLI | Akili, Inc. | Shanbhag Santosh | CFO | S - Sale | $1.05 | -830 | 323,636 | 0% | -$872 | ||||||
2023-09-12 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $106.56 | -600 | 23,731 | -2% | -$63,936 | ||||||
| D | 2023-09-11 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $298.76 | -9,666 | 957,582 | -1% | -$2,887,821 | |||||
| M | 2023-09-12 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $43.87 | -10,000 | 5,037,950 | 0% | -$438,712 | |||||
2023-09-11 | HAE | Haemonetics Corp | Lingamneni Anila | EVP, CTO | S - Sale | $90.00 | -2,305 | 14,495 | -14% | -$207,450 | ||||||
2023-09-12 | HAE | Haemonetics Corp | Strong Stewart W | Pres, Global Hospital | S - Sale | $90.65 | -228 | 16,221 | -1% | -$20,668 | ||||||
| D | 2023-09-08 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale+OE | $0.00 | -47,992 | 228,859 | -17% | -$0 | |||||
| DM | 2022-11-28 | NORD | Nordicus Partners Corp | Gk Partners Aps | 10% | S - Sale+OE | $0.85 | -5,722,786 | 2,933,071 | -66% | -$4,862,497 | |||||
| DM | 2023-02-28 | NORD | Nordicus Partners Corp | Gk Partners Aps | 10% | P - Purchase | $0.99 | +4,903,618 | 2,933,071 | -249% | +$4,870,184 | |||||
2023-09-11 | ATEC | Alphatec Holdings, Inc. | Mowry David H | Dir | S - Sale | $14.46 | -9,500 | 92,381 | -9% | -$137,370 | ||||||
2023-09-11 | ATEC | Alphatec Holdings, Inc. | Tullis James L L | Dir | S - Sale | $14.74 | -105,000 | 1,741,821 | -6% | -$1,547,700 | ||||||
2023-09-11 | UBI | Universal Biosensors Inc | Coleman Craig E. | Dir, 10% | P - Purchase | $0.22 | +100,000 | 61,392,221 | 0% | +$22,000 | ||||||
2023-09-08 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $288.66 | -444 | 9,958 | -4% | -$128,165 | ||||||
| D | 2023-09-12 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $53.91 | -113,355 | 1,675,167 | -6% | -$6,110,447 | |||||
2023-09-11 | PSTV | Plus Therapeutics, Inc. | Petersen Greg | Dir | P - Purchase | $1.70 | +20,000 | 24,166 | +480% | +$34,062 | ||||||
2023-09-08 | ICUI | Icu Medical Inc/de | Voigtlander Christian B. | COO | S - Sale | $129.04 | -6,850 | 13,603 | -33% | -$883,930 | ||||||
| M | 2023-09-07 | VAPO | Vapotherm Inc | Army Joseph | Pres, CEO | P - Purchase | $3.48 | +100,000 | 432,783 | +30% | +$347,992 | |||||
2023-09-08 | EMBC | Embecta Corp. | Melcher David F | Dir | P - Purchase | $15.77 | +6,233 | 27,698 | +29% | +$98,271 | ||||||
2023-09-06 | INFU | Infusystem Holdings, Inc | Malhotra R. Rimmy | Dir | S - Sale | $10.09 | -12,500 | 68,225 | -15% | -$126,073 | ||||||
| D | 2023-08-31 | ARTH | Arch Therapeutics, Inc. | Abrams Michael S | CFO | P - Purchase | $0.28 | +10,292 | 10,292 | New | +$2,830 | |||||
| D | 2023-08-31 | ARTH | Arch Therapeutics, Inc. | Norchi Terrence W | Pres, CHIEF Exec | P - Purchase | $0.28 | +6,862 | 6,862 | New | +$1,887 | |||||
| D | 2023-08-31 | ARTH | Arch Therapeutics, Inc. | Hicks Laurence | Dir | P - Purchase | $0.28 | +10,292 | 10,292 | New | +$2,830 | |||||
2023-08-21 | RCEL | Avita Medical, Inc. | Shiroma Donna | GC | S - Sale | $15.84 | -4,193 | 42,257 | -9% | -$66,417 | ||||||
2023-09-06 | SYK | Stryker Corp | Menon Viju | Group Pres | S - Sale | $289.00 | -5,000 | 7,145 | -41% | -$1,445,000 | ||||||
2023-09-05 | HAE | Haemonetics Corp | Dockendorff Charles J | Dir | S - Sale | $87.68 | -10,215 | 20,141 | -34% | -$895,651 | ||||||
2023-09-01 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $161.15 | -25 | 7,408 | 0% | -$4,029 | ||||||
2023-09-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $265.11 | -600 | 64,237 | -1% | -$159,067 | ||||||
2023-09-01 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $266.62 | -340 | 9,320 | -4% | -$90,651 | ||||||
2023-09-01 | PEN | Penumbra Inc | Sarna Surbhi | Dir | S - Sale | $266.62 | -85 | 2,465 | -3% | -$22,663 | ||||||
2023-09-01 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $266.62 | -100 | 4,364 | -2% | -$26,662 | ||||||
| D | 2023-09-01 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $22.61 | -20,000 | 202,225 | -9% | -$452,192 | |||||
2023-09-01 | UFPT | Ufp Technologies Inc | Bailly R Jeffrey | Pres, CEO | S - Sale | $176.06 | -1,874 | 91,554 | -2% | -$329,936 | ||||||
2023-09-01 | LUNG | Pulmonx Corp | Sung Derrick | CFO | S - Sale | $10.00 | -4,219 | 391,041 | -1% | -$42,201 | ||||||
2023-09-01 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $10.01 | -2,843 | 253,021 | -1% | -$28,458 | ||||||
2023-09-01 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $10.01 | -3,772 | 153,648 | -2% | -$37,758 | ||||||
2023-09-01 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $10.01 | -6,527 | 1,168,020 | -1% | -$65,335 | ||||||
2023-09-01 | ARAY | Accuray Inc | Pervaiz Ali | SVP CFO | S - Sale | $2.85 | -8,195 | 405,160 | -2% | -$23,356 | ||||||
2023-09-05 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $47.59 | -10,000 | 5,047,950 | 0% | -$475,939 | ||||||
2023-09-05 | BDX | Becton Dickinson & Co | Byrd Richard | EVP, Pres Interventional | S - Sale | $274.48 | -459 | 3,444 | -12% | -$125,986 | ||||||
| M | 2023-08-31 | INFU | Infusystem Holdings, Inc | Malhotra R. Rimmy | Dir | S - Sale | $10.28 | -27,500 | 80,725 | -25% | -$282,652 | |||||
2023-09-01 | NVCR | Novocure Ltd | Cordova Ashley | CFO | S - Sale | $21.82 | -883 | 99,650 | -1% | -$19,265 | ||||||
2023-09-01 | NVCR | Novocure Ltd | Groenhuysen Wilhelmus Cm | COO | S - Sale | $21.82 | -294 | 209,825 | 0% | -$6,414 | ||||||
2023-09-01 | NVCR | Novocure Ltd | Shah Pritesh | Chief Growth Officer | S - Sale | $21.82 | -273 | 124,893 | 0% | -$5,956 | ||||||
| M | 2023-08-31 | INBS | Intelligent Bio Solutions Inc. | Simeonidis Harry | CEO | P - Purchase | $1.90 | +150 | 4,180 | +4% | +$285 | |||||
2023-08-28 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $4.69 | +3,400 | 246,400 | +1% | +$15,946 | ||||||
2023-09-01 | DXCM | Dexcom Inc | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | S - Sale | $102.32 | -56 | 33,569 | 0% | -$5,730 | ||||||
| D | 2023-08-30 | WST | West Pharmaceutical Services Inc | Favorite Annette F | SVP, CHRO | S - Sale+OE | $414.64 | -2,000 | 14,877 | -12% | -$829,277 | |||||
| M | 2023-08-30 | MODD | Modular Medical, Inc. | Frank Morgan C. | Dir, 10% | P - Purchase | $1.07 | +145,949 | 206,226 | +242% | +$155,507 | |||||
| M | 2023-08-30 | UFPT | Ufp Technologies Inc | Bailly R Jeffrey | Pres, CEO | S - Sale | $176.45 | -16,501 | 93,428 | -15% | -$2,911,657 | |||||
| M | 2023-08-30 | VAPO | Vapotherm Inc | Arnerich Anthony L. | Dir | P - Purchase | $3.11 | +37,750 | 1,557,719 | +2% | +$117,337 | |||||
| M | 2023-08-16 | CTCX | Carmell Corp | Shukla Rajiv | Exec COB, 10% | P - Purchase | $3.59 | +8,612 | 4,258,520 | 0% | +$30,880 | |||||
| M | 2023-08-17 | CTCX | Carmell Corp | Hubbell Randolph W | Pres, CEO | P - Purchase | $3.67 | +2,750 | 2,750 | New | +$10,091 | |||||
| M | 2023-08-28 | INFU | Infusystem Holdings, Inc | Malhotra R. Rimmy | Dir | S - Sale | $10.29 | -20,000 | 108,225 | -16% | -$205,769 | |||||
| M | 2023-08-28 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $47.32 | -10,000 | 5,057,950 | 0% | -$473,188 | |||||
| M | 2023-08-28 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $53.48 | -18,628 | 60,588 | -24% | -$996,230 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |